RXO (NYSE:RXO) Given New $20.00 Price Target at Susquehanna

RXO (NYSE:RXOFree Report) had its price objective hoisted by Susquehanna from $14.00 to $20.00 in a report issued on Thursday, Benzinga reports. They currently have a negative rating on the stock.

RXO has been the subject of a number of other reports. Raymond James initiated coverage on shares of RXO in a report on Wednesday, May 15th. They issued a market perform rating for the company. JPMorgan Chase & Co. upped their price objective on shares of RXO from $25.00 to $26.00 and gave the stock an underweight rating in a report on Thursday, August 8th. TD Cowen boosted their target price on shares of RXO from $23.00 to $28.00 and gave the stock a hold rating in a research report on Thursday, August 8th. UBS Group boosted their target price on shares of RXO from $22.00 to $31.00 and gave the stock a neutral rating in a research report on Thursday, August 8th. Finally, Barclays boosted their target price on shares of RXO from $24.00 to $30.00 and gave the stock an overweight rating in a research report on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of Hold and a consensus price target of $26.00.

Get Our Latest Analysis on RXO

RXO Trading Up 1.3 %

Shares of NYSE:RXO opened at $29.03 on Thursday. The stock has a market capitalization of $3.41 billion, a PE ratio of -322.56, a P/E/G ratio of 7.13 and a beta of 1.38. RXO has a 1 year low of $16.94 and a 1 year high of $32.82. The firm has a fifty day moving average price of $26.80 and a 200 day moving average price of $22.84. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.03. The firm had revenue of $930.00 million during the quarter, compared to analysts’ expectations of $934.14 million. RXO had a negative net margin of 0.55% and a positive return on equity of 2.22%. RXO’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.08 earnings per share. Analysts expect that RXO will post 0.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RXO. Swedbank AB acquired a new position in shares of RXO during the first quarter valued at about $76,982,000. MFN Partners Management LP raised its position in shares of RXO by 19.8% during the first quarter. MFN Partners Management LP now owns 15,588,555 shares of the company’s stock valued at $340,922,000 after buying an additional 2,580,330 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its stake in RXO by 1,459.0% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,628,080 shares of the company’s stock valued at $42,574,000 after acquiring an additional 1,523,650 shares during the period. Motley Fool Asset Management LLC increased its stake in RXO by 287.9% in the first quarter. Motley Fool Asset Management LLC now owns 1,582,324 shares of the company’s stock valued at $34,605,000 after acquiring an additional 1,174,361 shares during the period. Finally, Norges Bank bought a new stake in RXO in the fourth quarter valued at about $24,250,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.